SKI Market

A+| A| A-|

Indian Indices

Sensex

76,987.57 179.09
( 0.23%)

Global Indices

Nasdaq

52,022.73 330.70
(0.64%)

Dow Jones

7,531.82 -43.47
(-0.57%)

Hang Seng

69,393.70 76.20
(0.11%)

Nikkei 225

10,504.45 73.83
(0.71%)

Forex

USD-INR

94.63 -0.29
(-0.31%)

EUR-INR

109.79 -0.04
(-0.03%)

GBP-INR

127.09 -0.16
(-0.13%)

JPY-INR

0.59 0.00
(-0.29%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

REC Ltd

Industry : Finance - Term-Lending Institutions

BSE Code

ISIN Demat

Book Value()

532955

INE020B01018

320.1034701

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

RECLTD

5.76

93848.1

EPS(TTM)

Face Value()

Div & Yield %

61.83

5.2

Back

bosch ltd

Novartis India standalone net profit declines 13.82% in the March 2026 quarter

May 12,2026

Net profit of Novartis India declined 13.82% to Rs 25.25 crore in the quarter ended March 2026 as against Rs 29.30 crore during the previous quarter ended March 2025. Sales rose 7.95% to Rs 90.55 crore in the quarter ended March 2026 as against Rs 83.88 crore during the previous quarter ended March 2025.

For the full year,net profit declined 7.65% to Rs 93.18 crore in the year ended March 2026 as against Rs 100.90 crore during the previous year ended March 2025. Sales declined 0.54% to Rs 354.33 crore in the year ended March 2026 as against Rs 356.27 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	90.55	83.88	8	354.33	356.27	-1
OPM %	22.77	28.51	-	26.56	25.66	-
PBDT	30.56	34.42	-11	131.61	132.61	-1
PBT	30.14	33.89	-11	129.66	130.42	-1
NP	25.25	29.30	-14	93.18	100.90	-8

76,987.57 179.09 ( 0.23%)

52,022.73 330.70 (0.64%)

7,531.82 -43.47 (-0.57%)

69,393.70 76.20 (0.11%)

10,504.45 73.83 (0.71%)

94.63 -0.29 (-0.31%)

109.79 -0.04 (-0.03%)

127.09 -0.16 (-0.13%)

0.59 0.00 (-0.29%)